Article
A MiRNA-based Signature is Associated With Tumor Mutational Burden in Colon Adenocarcinoma
2020-06-25
Abstract excerpt
<h4>Background: </h4> Tumor mutation burden (TMB) has become an independent biomarker for predicting the response of Immune checkpoint inhibitors.MiRNA plays an important role in cancer-related immune regulation but the relationship between expression of miRNA and TMB is unclear in colon adenocarcinoma (COAD). <h4>Method: </h4> The transcriptome profiling data, clinical data, mutation annotation data and miRNA exp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2b83dd7b-1299-5b6a-b10f-44be3b9ecb34
- DOI
- 10.21203/rs.3.rs-37405/v1
